Investment and commercialisation group with a portfolio of life science, sustainability and technology companies
NetScientific plc (AIM: NSCI) is deep tech and life sciences VC investment group with an international portfolio of innovative companies.
NetScientific identifies, invests in, and builds high growth companies in the UK and internationally. The company adds value through the proactive management of its portfolio, progressing to key value inflection points, and delivering investment returns through partial or full liquidity events.
NetScientific differentiates itself by employing a capital-light investment approach, making judicial use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital. The group secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a lean structure that can support a large portfolio.
NetScientific is headquartered in London, United Kingdom, and is admitted to trading on AIM, a market operated by the London Stock Exchange.
Technology, Healthcare, Sustainability, Venture Capital, Medtech, Robotics, Industrial High Tech, Biotech, Diagnostics, Therapeutics, AIM, PLC, and FTSE
NetScientific plc (AIM: NSCI) is an investment and commercialisation group with an international portfolio of innovative life science, sustainability and technology companies.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
BNP Paribas Bank, Banking | BNP Paribas Bank, Banking | Other 29 Jun 2023 | | |
LRM Venture Capital and Private Equity Principals | LRM Venture Capital and Private Equity Principals | Other 19 Jan 2023 | | |
EMV Capital Venture Capital and Private Equity Principals | EMV Capital Venture Capital and Private Equity Principals | Other 29 Nov 2022 29 Feb 2024 | | |
Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Other 30 Sep 2023 | |